ERNDIMQA - Neurotransmitters in CSF
| Purpose: | Comparison of Neurotransmitter metabolite outcome in a lab in respect to median and target values |
| Scientific Expert: | Dr Simon Pope simon.pope@uclh.nhs.uk |
| Scheme Organiser: | Dr. E. van der Hagen e-mail: E.vanderhagen@skbwinterswijk.nl |
| Analytes: | Homovanillic acid (HVA), 5-hydroxyindole acetic acid (5-HIAA), 3-methyl dopa (3-MD) and 5-hydroxytryptophan (5-HTTP), HVA:5-HIAA ratio |
| Number of Specimens/Year: | 8 |
| Matrix of the Specimens: | A mixture of spiked/diluted lyophilised cerebrospinal spinal fluid (CSF) and artifical CSF |
| Volume/Specimen: | 500µl/vial |
| Number of Shipments/Year: | One shipment of 8 specimens in February |
| Submission of Results: | Via ERNDIM Interactive Website |
| Reports: | Requested from ERNDIM Interactive Website |
| Certificate: | Once a year issued by ERNDIM Board |
| Number of Participants: | 34 (2019) |
| Status of the Scheme: | Pilot scheme in 2014-2015, full scheme from 2016 |
| Geographic Area: | Worldwide |
| Limitation Participation: | None |
| Cost/Year: | 391 EURO (2021) |
| How to subscribe: | e-mail: admin@erndim.org |
| | Click here for Annual Reports |
